233 related articles for article (PubMed ID: 16298347)
1. Targeting the forgotten transglycosylases.
Halliday J; McKeveney D; Muldoon C; Rajaratnam P; Meutermans W
Biochem Pharmacol; 2006 Mar; 71(7):957-67. PubMed ID: 16298347
[TBL] [Abstract][Full Text] [Related]
2. Bacterial transglycosylase inhibitors.
Ostash B; Walker S
Curr Opin Chem Biol; 2005 Oct; 9(5):459-66. PubMed ID: 16118062
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity of synthetic analogues based on the disaccharide structure of moenomycin, an inhibitor of bacterial transglycosylase.
Baizman ER; Branstrom AA; Longley CB; Allanson N; Sofia MJ; Gange D; Goldman RC
Microbiology (Reading); 2000 Dec; 146 Pt 12():3129-3140. PubMed ID: 11101671
[TBL] [Abstract][Full Text] [Related]
4. Small molecule inhibitors of peptidoglycan synthesis targeting the lipid II precursor.
Derouaux A; Turk S; Olrichs NK; Gobec S; Breukink E; Amoroso A; Offant J; Bostock J; Mariner K; Chopra I; Vernet T; Zervosen A; Joris B; Frère JM; Nguyen-Distèche M; Terrak M
Biochem Pharmacol; 2011 May; 81(9):1098-105. PubMed ID: 21356201
[TBL] [Abstract][Full Text] [Related]
5. Does the cell wall of bacteria remain a viable source of targets for novel antibiotics?
Silver LL
Biochem Pharmacol; 2006 Mar; 71(7):996-1005. PubMed ID: 16290173
[TBL] [Abstract][Full Text] [Related]
6. Prospects for novel inhibitors of peptidoglycan transglycosylases.
Galley NF; O'Reilly AM; Roper DI
Bioorg Chem; 2014 Aug; 55(100):16-26. PubMed ID: 24924926
[TBL] [Abstract][Full Text] [Related]
7. Structural details of the glycosyltransferase step of peptidoglycan assembly.
Lovering AL; Gretes M; Strynadka NC
Curr Opin Struct Biol; 2008 Oct; 18(5):534-43. PubMed ID: 18721881
[TBL] [Abstract][Full Text] [Related]
8. Hydrophobic substituents on isatin derivatives enhance their inhibition against bacterial peptidoglycan glycosyltransferase activity.
Wang Y; Cheong WL; Liang Z; So LY; Chan KF; So PK; Chen YW; Wong WL; Wong KY
Bioorg Chem; 2020 Apr; 97():103710. PubMed ID: 32146179
[TBL] [Abstract][Full Text] [Related]
9. Targeting Bacterial Cell Wall Peptidoglycan Synthesis by Inhibition of Glycosyltransferase Activity.
Mesleh MF; Rajaratnam P; Conrad M; Chandrasekaran V; Liu CM; Pandya BA; Hwang YS; Rye PT; Muldoon C; Becker B; Zuegg J; Meutermans W; Moy TI
Chem Biol Drug Des; 2016 Feb; 87(2):190-9. PubMed ID: 26358369
[TBL] [Abstract][Full Text] [Related]
10. Emerging bacterial enzyme targets.
Su Z; Honek JF
Curr Opin Investig Drugs; 2007 Feb; 8(2):140-9. PubMed ID: 17328230
[TBL] [Abstract][Full Text] [Related]
11. The molecular biology of moenomycins: towards novel antibiotics based on inhibition of bacterial peptidoglycan glycosyltransferases.
Ostash B; Doud E; Fedorenko V
Biol Chem; 2010 May; 391(5):499-504. PubMed ID: 20302515
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
Lu H; Tonge PJ
Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
[TBL] [Abstract][Full Text] [Related]
13. A multivalent approach to drug discovery for novel antibiotics.
Long DD; Aggen JB; Christensen BG; Judice JK; Hegde SS; Kaniga K; Krause KM; Linsell MS; Moran EJ; Pace JL
J Antibiot (Tokyo); 2008 Oct; 61(10):595-602. PubMed ID: 19168973
[TBL] [Abstract][Full Text] [Related]
14. Structure-based design, synthesis, and biological evaluation of isatin derivatives as potential glycosyltransferase inhibitors.
Wang Y; Chan FY; Sun N; Lui HK; So PK; Yan SC; Chan KF; Chiou J; Chen S; Abagyan R; Leung YC; Wong KY
Chem Biol Drug Des; 2014 Dec; 84(6):685-96. PubMed ID: 24890564
[TBL] [Abstract][Full Text] [Related]
15. Peptidoglycan biosynthesis machinery: a rich source of drug targets.
Gautam A; Vyas R; Tewari R
Crit Rev Biotechnol; 2011 Dec; 31(4):295-336. PubMed ID: 21091161
[TBL] [Abstract][Full Text] [Related]
16. Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains.
Wiener JJ; Gomez L; Venkatesan H; Santillán A; Allison BD; Schwarz KL; Shinde S; Tang L; Hack MD; Morrow BJ; Motley ST; Goldschmidt RM; Shaw KJ; Jones TK; Grice CA
Bioorg Med Chem Lett; 2007 May; 17(10):2718-22. PubMed ID: 17382544
[TBL] [Abstract][Full Text] [Related]
17. Peptide inhibitors of MurD and MurE, essential enzymes of bacterial cell wall biosynthesis.
Bratkovic T; Lunder M; Urleb U; Strukelj B
J Basic Microbiol; 2008 Jun; 48(3):202-6. PubMed ID: 18506905
[TBL] [Abstract][Full Text] [Related]
18. Mode of action of lipid II-targeting lantibiotics.
Bauer R; Dicks LM
Int J Food Microbiol; 2005 May; 101(2):201-16. PubMed ID: 15862882
[TBL] [Abstract][Full Text] [Related]
19. New continuous fluorometric assay for bacterial transglycosylase using Förster resonance energy transfer.
Huang SH; Wu WS; Huang LY; Huang WF; Fu WC; Chen PT; Fang JM; Cheng WC; Cheng TJ; Wong CH
J Am Chem Soc; 2013 Nov; 135(45):17078-89. PubMed ID: 24131464
[TBL] [Abstract][Full Text] [Related]
20. Dihydrofolate reductase inhibitors as antibacterial agents.
Hawser S; Lociuro S; Islam K
Biochem Pharmacol; 2006 Mar; 71(7):941-8. PubMed ID: 16359642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
